文档介绍：EBioMedicine 34 (2018) 94–107
Contents lists available at ScienceDirect
EBioMedicine
journal homepage:
Research Paper
Using microRNAs as Novel Predictors of Urologic Cancer Survival: An
Integrated Analysis
Zhicong Chen a,1, Yonghao Zhan a,1, Jieshan Chi b,c,1, Shuyuan Guo b,1,XinliangZhongb, Anbang He a,
Jianrong Zheng b, Yanqing Gong a, Xuesong Li a,⁎, Liqun Zhou a,⁎
a Department of Urology, Peking University First Hospital, The Institute of Urology, Peking University, National Urological Cancer Centre, Beijing 100034, China
b Shantou University Medical College, Shantou 515041, China
c Department of Neurology, Guangdong Neuroscience Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China
article info abstract
Article history: Background: MicroRNAs(miRNAs) are involved in the formation, maintenance, and metastasis of urologic cancer.
Received 30 May 2018 Here, we aim to gather and evaluate all of the evidence regarding the potential role of miRNAs as novel predictors
Received in revised form 3 July 2018 of urologic cancer survival.
Accepted 12 July 2018 Methods: A systematic review was performed to identify and score all of the published studies that evaluated the
Available online 21 July 2018
prognostic effects of miRNAs in kidney (KCa), bladder (BCa) or prostate cancer (PCa). Where appropriate, the
summary effects of miRNAs on urologic cancer were meta-a